Agency Information Collection Activities: Submission to OMB for Review and Approval; Public Comment Request; Rural Health Opioid Program Grant Performance Measures, OMB No. 0906-xxxx-NEW, 20080-20081 [2018-09668]

Download as PDF 20080 Federal Register / Vol. 83, No. 88 / Monday, May 7, 2018 / Notices The proposed Rural Quality draft measures reflect a reduced number of required measures and improvements to the number of optional measures including the following: 24 total measures (previously 43), which includes 16 required measures applicable to all awardees in addition to improved optional measure choices for 8 total optional measures (previously 4). Proposed revisions specifically include the following: (1) Alignment of clinical measures to current National Quality Forum endorsement recommendations and (2) broadened orientation of measures for improved applicability across variety of rural quality improvement project topic areas. With the continuing shift in the healthcare environment towards provision of value-based care and utilization of reimbursement strategies through Centers for Medicare and Medicaid quality reporting programs, the latest competitive cohort also aligns with this shift. An increased number of sophisticated applicants leveraging increasingly intricate reporting methodologies for quality data collection, utilization, and analysis has resulted in an estimate of burden hours more in line with the realities of the health care landscape. Likely Respondents: The respondents would be award recipients of the Small Health Care Provider Quality Improvement Program. Burden Statement: Burden in this context means the time expended by persons to generate, maintain, retain, disclose or provide the information requested. This includes the time needed to review instructions; to develop, acquire, install and utilize technology and systems for the purpose of collecting, validating and verifying information, processing and maintaining information, and disclosing and providing information; to train personnel and to be able to respond to a collection of information; to search data sources; to complete and review the collection of information; and to transmit or otherwise disclose the information. The total annual burden hours estimated for this ICR are summarized in the table below. TOTAL ESTIMATED ANNUALIZED BURDEN—HOURS Number of respondents Form name Small Health Care Provider Quality Improvement Program Performance Improvement Measurement System (PIMS) Measurement ....................................................... Amy P. McNulty, Acting Director, Division of the Executive Secretariat. [FR Doc. 2018–09674 Filed 5–4–18; 8:45 am] BILLING CODE 4165–15–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Health Resources and Services Administration Agency Information Collection Activities: Submission to OMB for Review and Approval; Public Comment Request; Rural Health Opioid Program Grant Performance Measures, OMB No. 0906–xxxx—NEW Health Resources and Services Administration (HRSA), Department of Health and Human Services. ACTION: Notice. AGENCY: In compliance with the Paperwork Reduction Act of 1995, HRSA has submitted an Information Collection Request (ICR) to the Office of Management and Budget (OMB) for review and approval. HRSA published the 60-day notice on December 15, 2017, FR Doc. 2017–27013. HRSA received one comment. Comments submitted during the first public review of this ICR will be provided to OMB. OMB will accept further comments from the daltland on DSKBBV9HB2PROD with NOTICES SUMMARY: VerDate Sep<11>2014 17:38 May 04, 2018 Jkt 244001 32 32 Number of responses per respondent 1 ........................ public during the review and approval period. DATES: Comments on this ICR should be received no later than June 6, 2018. ADDRESSES: Submit your comments, including the ICR Title, to the desk officer for HRSA, either by email to OIRA_submission@omb.eop.gov or by fax to (202) 395–5806. FOR FURTHER INFORMATION CONTACT: To request a copy of the clearance requests submitted to OMB for review, email Lisa Wright-Solomon, the HRSA Information Collection Clearance Officer at paperwork@hrsa.gov or call (301) 443– 1984. SUPPLEMENTARY INFORMATION: Information Collection Request Title: Rural Health Opioid Program Grant Performance Measures OMB No. 0906–xxxx—NEW Abstract: The Rural Health Opioid Program aims to promote rural health care services outreach by expanding the delivery of opioid related health care services to rural communities. The program will work to reduce the morbidity and mortality related to opioid overdoses in rural communities through the development of broad community consortiums to prepare individuals with opioid-use disorder to start treatment, implement care coordination practices to organize patient care activities, and support PO 00000 Frm 00049 Fmt 4703 Sfmt 4703 Average burden per response (in hours) Total responses 32 32 22 ........................ Total burden hours 704 704 individuals in recovery through the enhancement of behavioral counselling and peer support activities. Need and Proposed Use of the Information: For this program, performance measures were drafted to provide data to the program and to enable HRSA to provide aggregate program data required by Congress under the Government Performance and Results Act of 1993. These measures cover the principal topic areas of interest to the Federal Office of Rural Health Policy (FORHP), including: (a) Target population demographics; (b) referrals to substance abuse treatment; (c) substance abuse treatment process and outcomes; (d) education of health care providers and community members; and (e) rates of fatal and nonfatal opioid-related overdose. All measures will speak to FORHP’s progress toward meeting the goals set. Likely Respondents: The respondents would be recipients of the Rural Health Opioid Program grant funding. Burden Statement: Burden in this context means the time expended by persons to generate, maintain, retain, disclose or provide the information requested. This includes the time needed to review instructions; to develop, acquire, install and utilize technology and systems for the purpose of collecting, validating and verifying information, processing and E:\FR\FM\07MYN1.SGM 07MYN1 20081 Federal Register / Vol. 83, No. 88 / Monday, May 7, 2018 / Notices maintaining information, and disclosing and providing information; to train personnel and to be able to respond to a collection of information; to search data sources; to complete and review the collection of information; and to transmit or otherwise disclose the information. The total annual burden hours estimated for this ICR are summarized in the table below. TOTAL ESTIMATED ANNUALIZED BURDEN—HOURS Number of respondents Form name Number of responses per respondent Average burden per response (in hours) Total responses Total burden hours Rural Health Opioid Program Grant Performance Measures ................................................................................... 10 1 10 11 110 Total .............................................................................. 10 ........................ 10 ........................ 110 Microbiology and Infectious Diseases Research, National Institutes of Health, HHS) Amy P. McNulty, Acting Director, Division of the Executive Secretariat. [FR Doc. 2018–09668 Filed 5–4–18; 8:45 am] BILLING CODE 4165–15–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting daltland on DSKBBV9HB2PROD with NOTICES Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The contract proposals and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the contract proposals, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Allergy and Infectious Diseases Special Emphasis Panel PHS, 2017–1 NIAID Topic 43 (Adjuvant Development). Date: May 30, 2018. Time: 10:30 a.m. to 12:30 p.m. Agenda: To review and evaluate contract proposals. Place: National Institutes of Health, 5601 Fishers Lane, Rockville, MD 20892 (Telephone Conference Call). Contact Person: Thomas F. Conway, Ph.D., Scientific Review Officer, Scientific Review Program, Division of Extramural Activities, Room 3G51, National Institutes of Health, NIAID, 5601 Fishers Lane, MSC 9823, Bethesda, MD 20892–9823, 240–507–9685, thomas.conway@nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.855, Allergy, Immunology, and Transplantation Research; 93.856, VerDate Sep<11>2014 17:38 May 04, 2018 Jkt 244001 Transfer and Development, 31 Center Drive Room 4A29, MSC2479, Bethesda, MD 20892–2479; Telephone: +1–301– Dated: May 2, 2018. 435–4507; Fax: +1–301–594–3080; Natasha M. Copeland, Email: thalhamc@mail.nih.gov. Program Analyst, Office of Federal Advisory SUPPLEMENTARY INFORMATION: The Committee Policy. following represents the intellectual [FR Doc. 2018–09659 Filed 5–4–18; 8:45 am] property to be licensed under the BILLING CODE 4140–01–P prospective agreement: U.S. Provisional Patent Application No. 61/488,671, filed May 20, 2011; PCT DEPARTMENT OF HEALTH AND Application. No. PCT/US2012/028926, HUMAN SERVICES filed March 13, 2012; U.S. Patent No. 9,068,003, issued June 30, 2015; U.S. National Institutes of Health Patent No. 9,896,511, issued February Prospective Grant of Exclusive Patent 20, 2018; and U.S. Patent Application License: Antibodies Against TL1A, a No. 15/872,592, filed January 16, 2018, TNF-Family Cytokine, for the ‘‘Antibodies Against TL1A, a TNFTreatment and Diagnosis of Crohn’s Family Cytokine, for the Treatment and Disease, Ulcerative Colitis, Asthma, Diagnosis of Autoimmune Inflammatory Psoriasis and Biliary Cirrhosis Diseases’’, NIH Reference No. E–073– 2011/0,1,2. AGENCY: National Institutes of Health, With respect to persons who have an HHS. obligation to assign their right, title and ACTION: Notice. interest to the Government of the United SUMMARY: The National Heart, Lung, and States of America, the patent rights in these inventions have been assigned to Blood Institute (‘‘NHLBI’’), an institute the Government of the United States of of the National Institutes of Health; an agency within the Department of Health America. The prospective exclusive license and Human Services, is contemplating territory may be worldwide and the the grant of an exclusive patent license field of use may be limited to the use to commercialize the invention(s) of Licensed Patent Rights for the embodied in the intellectual property following: ‘‘Development and estate stated in the Summary commercialization of antibodies against Information section of this notice to TL1A for the treatment and diagnosis of Precision IBD, Inc., located in San Crohn’s Disease, Ulcerative Colitis, Diego, California, and incorporated Asthma, Psoriasis and Biliary Cirrhosis’’ under the laws of Delaware. The subject technology is based on DATES: Only written comments and/or the use of antibodies against TL1A, a applications for a license which are TNF-Family cytokine, for the treatment received by the NHLBI Office of and diagnosis of autoimmune Technology Transfer and Development inflammatory diseases. Autoimmune on or before May 22, 2018 will be inflammatory diseases occur in greater considered. than five percent of the U.S. population. Treatments generally include ADDRESSES: Requests for copies of the immunosuppressants or antipatent application, inquiries, and inflammatory drugs, which can have comments relating to the contemplated serious side effects. Recently, more exclusive license should be directed to: specific immunomodulatory therapies Cristina Thalhammer-Reyero, Ph.D., such as TNF-alpha antagonists have MBA, Senior Licensing and Patenting been developed. In experiments with Manager, NHLBI Office of Technology PO 00000 Frm 00050 Fmt 4703 Sfmt 4703 E:\FR\FM\07MYN1.SGM 07MYN1

Agencies

[Federal Register Volume 83, Number 88 (Monday, May 7, 2018)]
[Notices]
[Pages 20080-20081]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-09668]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Health Resources and Services Administration


Agency Information Collection Activities: Submission to OMB for 
Review and Approval; Public Comment Request; Rural Health Opioid 
Program Grant Performance Measures, OMB No. 0906-xxxx--NEW

AGENCY: Health Resources and Services Administration (HRSA), Department 
of Health and Human Services.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: In compliance with the Paperwork Reduction Act of 1995, HRSA 
has submitted an Information Collection Request (ICR) to the Office of 
Management and Budget (OMB) for review and approval. HRSA published the 
60-day notice on December 15, 2017, FR Doc. 2017-27013. HRSA received 
one comment. Comments submitted during the first public review of this 
ICR will be provided to OMB. OMB will accept further comments from the 
public during the review and approval period.

DATES: Comments on this ICR should be received no later than June 6, 
2018.

ADDRESSES: Submit your comments, including the ICR Title, to the desk 
officer for HRSA, either by email to [email protected] or by 
fax to (202) 395-5806.

FOR FURTHER INFORMATION CONTACT: To request a copy of the clearance 
requests submitted to OMB for review, email Lisa Wright-Solomon, the 
HRSA Information Collection Clearance Officer at [email protected] or 
call (301) 443-1984.

SUPPLEMENTARY INFORMATION: 
    Information Collection Request Title: Rural Health Opioid Program 
Grant Performance Measures
    OMB No. 0906-xxxx--NEW
    Abstract: The Rural Health Opioid Program aims to promote rural 
health care services outreach by expanding the delivery of opioid 
related health care services to rural communities. The program will 
work to reduce the morbidity and mortality related to opioid overdoses 
in rural communities through the development of broad community 
consortiums to prepare individuals with opioid-use disorder to start 
treatment, implement care coordination practices to organize patient 
care activities, and support individuals in recovery through the 
enhancement of behavioral counselling and peer support activities.
    Need and Proposed Use of the Information: For this program, 
performance measures were drafted to provide data to the program and to 
enable HRSA to provide aggregate program data required by Congress 
under the Government Performance and Results Act of 1993. These 
measures cover the principal topic areas of interest to the Federal 
Office of Rural Health Policy (FORHP), including: (a) Target population 
demographics; (b) referrals to substance abuse treatment; (c) substance 
abuse treatment process and outcomes; (d) education of health care 
providers and community members; and (e) rates of fatal and non-fatal 
opioid-related overdose. All measures will speak to FORHP's progress 
toward meeting the goals set.
    Likely Respondents: The respondents would be recipients of the 
Rural Health Opioid Program grant funding.
    Burden Statement: Burden in this context means the time expended by 
persons to generate, maintain, retain, disclose or provide the 
information requested. This includes the time needed to review 
instructions; to develop, acquire, install and utilize technology and 
systems for the purpose of collecting, validating and verifying 
information, processing and

[[Page 20081]]

maintaining information, and disclosing and providing information; to 
train personnel and to be able to respond to a collection of 
information; to search data sources; to complete and review the 
collection of information; and to transmit or otherwise disclose the 
information. The total annual burden hours estimated for this ICR are 
summarized in the table below.

                                    Total Estimated Annualized Burden--Hours
----------------------------------------------------------------------------------------------------------------
                                                     Number of                    Average burden
            Form name                Number of     responses per       Total       per response    Total burden
                                    respondents     respondent       responses      (in hours)         hours
----------------------------------------------------------------------------------------------------------------
Rural Health Opioid Program                   10               1              10              11             110
 Grant Performance Measures.....
                                 -------------------------------------------------------------------------------
    Total.......................              10  ..............              10  ..............             110
----------------------------------------------------------------------------------------------------------------


Amy P. McNulty,
Acting Director, Division of the Executive Secretariat.
[FR Doc. 2018-09668 Filed 5-4-18; 8:45 am]
 BILLING CODE 4165-15-P